Skip to Main content Skip to Navigation
Journal articles

Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases.

Abstract : Programmed cell death, which is part of the normal development of the central nervous system, is also implicated in various neurodegenerative disorders. Cysteine-dependent aspartate-specific proteases (caspases) play a pivotal role in the cascade of events leading to apoptosis. Many factors that inhibit cell death have now been identified, but the underlying mechanisms are not fully understood. Pituitary adenylate cyclase-activating polypeptide (PACAP) has been shown to exert neurotrophic activities during development and to prevent neuronal apoptosis induced by various insults such as ischemia. Most of the neuroprotective effects of PACAP are mediated through the PAC1 receptor. This receptor activates a transduction cascade of second messengers to stimulate Bcl-2 expression, which inhibits cytochrome c release and blocks the activation of caspases. The inhibitory effect of PACAP on the apoptotic cascade suggests that selective, stable, and potent PACAP derivatives could potentially be of therapeutic value for the treatment of post-traumatic and/or chronic neurodegenerative processes.
Document type :
Journal articles
Complete list of metadatas

https://hal-riip.archives-ouvertes.fr/pasteur-00819987
Contributor : Charles M. Dozois <>
Submitted on : Thursday, May 2, 2013 - 10:03:41 PM
Last modification on : Wednesday, January 29, 2020 - 1:50:02 PM

Links full text

Identifiers

Citation

Agnieszka Dejda, Valérie Jolivel, Steve Bourgault, Tommy Seaborn, Alain Fournier, et al.. Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases.. Journal of Molecular Neuroscience, Humana Press, 2008, 36 (1-3), pp.26-37. ⟨10.1007/s12031-008-9087-1⟩. ⟨pasteur-00819987⟩

Share

Metrics

Record views

185